This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Curious about which travel cards have no annual fees? Find the best options to maximize your travel rewards.
26,862 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Two must-see graphs explain a dramatic stock surge and outline why the rally could keep running. This guide translate...
Investors are asking if this lucid make investors wealthier. The answer lies in Lucid's disciplined path to scale, ma...
The bond market nearing threshold as long-term yields climb in a period of geopolitical tension and data surprises. T...
Cursor CEO warns that relying on AI to bootstrap software—often labeled vibe coding—could create fragile foundations ...
A notable stake reduction in NMI Holdings highlights how large investors weigh growth, risk, and value. Here’s what i...
April brought a notable rally for Plug Power. This piece breaks down the forces behind the surge, what it signals for...
CareTrust's Q1 2026 earnings reveal steady cash flow and rising occupancy. This article breaks down what the numbers ...
Lightstone opens access to 25,000+ multifamily units for accredited investors as rents rise in tight markets. The mov...
A hantavirus outbreak can spark biotech chatter, but three solid realities—limited demand, tough development paths, a...
A new Belden stake filed with the SEC shows an investment firm buying $89.5 million worth of shares. This article bre...
Dow futures slid while oil prices rose as Iran’s stalemate keeps a risk premium in play. Markets brace for inflation ...